Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RUXOLITINIB vs SABRIL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RUXOLITINIB vs SABRIL: Safety Overview

Metric RUXOLITINIB SABRIL
Total FAERS Reports 68,133 772
Deaths Reported 10,908 53
Death Rate 16.0% 6.9%
Hospitalizations 14,461 180
Average Patient Age 59.7 yrs 11.0 yrs
% Female Patients 48.8% N/A
FDA Approval Date Nov 16, 2011 N/A
Manufacturer Incyte Corporation N/A
Route TOPICAL N/A
Marketing Status Prescription N/A